Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) in One Fraction (SMART ONE)
A Feasibility Study of Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) in One Fraction for Inoperable Primary or Metastatic Carcinoma (SMART ONE)
Sponsor: Baptist Health South Florida
A NA clinical study on Metastatic Carcinoma, this trial is completed. The trial is conducted by Baptist Health South Florida and has accumulated 10 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Aug 2025 — Present [monthly]
Completed NA
-
Nov 2024 — Aug 2025 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
▶ Show 5 earlier versions
-
Sep 2023 — May 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2023 — Sep 2023 [monthly]
Recruiting NA
-
May 2022 — Jun 2023 [monthly]
Recruiting NA
-
Dec 2021 — May 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Not Yet Recruiting NA
First recorded
Jun 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Baptist Health South Florida
- Viewray Inc.
For direct contact, visit the study record on ClinicalTrials.gov .